Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trump Counts On China To Deliver In The Day Of The Coronavirus

Executive Summary

President dismisses fears of drug shortages as White House prepares to deliver US from dependence on China’s pharmaceutical manufacturing complex.

You may also be interested in...



Biopharma, Payers Seek National Guidelines For Prescribing Potential COVID-19 Drugs

Guidelines for US health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.

White House Hypes Chloroquine, A Drug Currently In Shortage, As Coronavirus Treatment Hope

Efficacy trials are under way and one supplier already has said it would restart production to meet the anticipated demand.

China’s Global Pharma Supply Chain Operations Resuming In Wake Of Outbreak, USP Says

USP reference standard sales showed slow resumption of API manufacturing in China and less-than-expected API use in India.

Related Content

Topics

UsernamePublicRestriction

Register

PS141864

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel